Literature DB >> 6386812

Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae.

G R Willsky, D A White, B C McCabe.   

Abstract

The effect of vanadium oxides on living systems may involve the in vivo conversion of vanadate and vanadyl ions. The addition of 5 mM orthovanadate (VO4(3-), V(V)), a known inhibitor of the (Na,K)-ATPase, to yeast cells stopped growth. In contrast, the addition of 5 mM vanadyl (VO2+, V(IV) stimulated growth. Orthovanadate addition to whole cells is known to stimulate various cellular processes. In yeast, both ions inhibited the plasma membrane Mg2+ ATPase and were transported into the cell as demonstrated with [48V]VO4(3-) and VO2+. ESR spectroscopy has been used to measure the cell-associated paramagnetic vandyl ion, while 51V NMR has detected cell-associated diamagnetic vanadium (e.g. V(V)). Cells were exposed to both toxic (5 mM) and nontoxic (1 mM) concentrations of vanadate in the culture medium. ESR showed that under both conditions, vanadate became cell associated and was converted to vanadyl which then accumulated in the cell culture medium. 51V NMR studies showed the accumulation of new cell-associated vanadium resonances identified as dimeric vanadate and decavanadate in cells exposed to toxic amounts of medium vanadate (5 mM). These vanadate compounds did not accumulate in cells exposed to 1 mM vanadate. These studies confirm that the inhibitory form of vanadium usually observed in in vitro experiments is vanadate, in one or more of its hydrated forms. These data also support the hypothesis that the stimulatory form of vanadium usually observed in whole cell experiments is the vanadyl ion or one or more of its liganded derivatives.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386812

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.

Authors:  D C Crans; M Mahroof-Tahir; A D Keramidas
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

2.  Recent perspectives into biochemistry of decavanadate.

Authors:  Manuel Aureliano
Journal:  World J Biol Chem       Date:  2011-10-26

3.  Vanadate-resistant yeast mutants are defective in protein glycosylation.

Authors:  L Ballou; R A Hitzeman; M S Lewis; C E Ballou
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Vanadate-resistant mutants of Saccharomyces cerevisiae show alterations in protein phosphorylation and growth control.

Authors:  C Kanik-Ennulat; N Neff
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  Effect of Na(3)VO(4) on the P State of Nitella translucens.

Authors:  R M Cruz-Mireles; I Ortega-Blake
Journal:  Plant Physiol       Date:  1991-05       Impact factor: 8.340

6.  Electrogenic transport properties of growing Arabidopsis root hairs : the plasma membrane proton pump and potassium channels.

Authors:  R R Lew
Journal:  Plant Physiol       Date:  1991-12       Impact factor: 8.340

7.  Isolation and characterization of vanadate-resistant mutants of Saccharomyces cerevisiae.

Authors:  G R Willsky; J O Leung; P V Offermann; E K Plotnick; S F Dosch
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

8.  Electron paramagnetic resonance studies and effects of vanadium in Saccharomyces cerevisiae.

Authors:  M A Zoroddu; M Fruianu; R Dallocchio; A Masia
Journal:  Biometals       Date:  1996-01       Impact factor: 2.949

9.  Characterization of vanadate-dependent NADH oxidation stimulated by Saccharomyces cerevisiae plasma membranes.

Authors:  L A Minasi; G R Willsky
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

10.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.